🔗 Share this article

An underground market for unapproved weight-loss medications is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Treatment Gaining Popularity Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to message these accounts privately for source information, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with thousands of members share “before and after” photos, administration instructions and claims of next-day UK delivery. Sellers market the substance there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Professionals Express Concerns

However, doctors and chemists have warned that the distribution of what remains an unapproved drug in the UK is worrisome and could lead to individuals injecting substances of unknown origin.

Several professionals said the popularity for the experimental drug could be linked to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the British medical regulations.

Some content creators attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach medicines, advertising, and consumer laws, potentially leading to fines, legal action or imprisonment.

Platform Response and Content Removal

According to TikTok, the platform has removed violative content and banned related keywords and query recommendations. The company said it was committed to keeping the platform secure and investing in strengthening compliance measures.

Digital Trading Operations

Investigations also found communities with up to nine thousand participants marketing retatrutide using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly brings up channels with thousands of members, populated with images of weight loss, positive testimonials and detailed guides for preparing or injecting at home.

Within minutes of entering one group, a seller posted contact information, where most transactions occur. The vendor provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about weight, health issues or previous experience.

Product Details and Costs

Inside these communities, posts display black plastic packages with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how long a injector should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for Telegram stated it regularly moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting materials they cannot confirm. Even if the science behind retatrutide is sound, these online products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the surge in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.

Her staff has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company experimental product not yet authorized … may subject users to potentially serious health risks”.